Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 4/20 | 0.77 |
| ▸ | CES2 | O00748 | 3/20 | 0.77 |
| ▸ | FNTA | P49354 | 2/20 | 0.63 |
| ▸ | FNTB | P49356 | 2/20 | 0.63 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | PAM | P19021 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL574185 | 0.88 | CES1 (1.00) | CES1CES2FNTAFNTBAKR1B1 | |
| SCHEMBL27842681 | 0.87 | CES1 (0.64) | CES1CES2FNTAFNTBAKR1B1 | |
| SCHEMBL28073965 | 0.86 | CES2 (0.57) | CES1CES2FNTAFNTBAKR1B1 | |
| Hydrochloric Acid SCHEMBL3111570 | 0.85 | CES1 (0.94) | CES1CES2FNTAFNTBAKR1B1 | |
| SCHEMBL27823588 | 0.85 | CES1 (0.61) | CES1CES2FNTAFNTBAKR1B1 | |
| SCHEMBL27842713 | 0.85 | CES1 (0.61) | CES1CES2FNTAFNTBAKR1B1 | |
| SCHEMBL28790015 | 0.85 | CES1 (0.61) | CES1CES2FNTAFNTBAKR1B1 | |
| SCHEMBL6010224 | 0.83 | CES2 (0.71) | CES1CES2FNTAFNTBAKR1B1 | |
| SCHEMBL20326368 | 0.81 | CES1 (0.56) | CES1CES2FNTAFNTBAKR1B1 | |
| SCHEMBL108493 | 0.80 | FNTA (0.67) | CES1CES2FNTAFNTBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117691175-A | Polymer solid electrolyte and metal lithium battery | 华南师范大学 | 2024-03-12 | — | — | CN | claimed |
| EP-2463374-A2 | Isolated alcohol dehydrogenase enzymes and uses thereof | Bio Architecture Lab, Inc. (US) | 2012-06-13 | — | — | EP | claimed |
| EP-2195440-A2 | BIOFUEL PRODUCTION | Bio Architecture Lab, Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| US-20090155873-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-18 | — | — | US | claimed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | claimed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| US-20250241898-A1 | Topical Benzimidazole Formulations and Methods for Use in Treating Inflammatory Dermatoses | JJR&D, LLC | 2025-07-31 | — | — | US | disclosed |
| EP-3230463-B2 | RAPID PRETREATMENT | APALTA PATENTS OUE (EE) | 2025-07-16 | — | — | EP | disclosed |
| EP-4543441-A2 | TOPICAL BENZIMIDAZOLE FORMULATIONS AND METHODS FOR USE IN TREATING INFLAMMATORY DERMATOSES | JJR&D, LLC (US) | 2025-04-30 | — | — | EP | disclosed |
| US-20240423959-A1 | TOPICAL BENZIMIDAZOLE FORMULATIONS AND METHODS FOR USE IN TREATING INFLAMMATORY DERMATOSES | JJR&D, LLC | 2024-12-26 | — | — | US | disclosed |
| US-20240425893-A1 | RAPID PRETREATMENT | Apalta Patents OÜ (EE) | 2024-12-26 | — | — | US | disclosed |
| US-12054761-B2 | Rapid pretreatment | Apalta Patents OÜ (EE) | 2024-08-06 | — | — | US | disclosed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | disclosed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | disclosed |
| EP-1228067-B1 | 5-MEMBERED N-HETEROCYCLIC COMPOUNDS WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2004-07-14 | — | — | EP | disclosed |
| EP-0391399-B1 | Electrophotographic photoreceptor | FUJI PHOTO FILM CO LTD (JP) | 1995-11-02 | — | — | EP | disclosed |
| US-5053302-A | Photosensitivity, durability | FUJI PHOTO FILM CO., LTD. (JP) | 1991-10-01 | — | — | US | disclosed |
| US-5019474-A | Containing tetrakisazo charge generating compound; high sensitivity, durability | FUJI PHOTO FILM CO., LTD. (JP) | 1991-05-28 | — | — | US | disclosed |
| EP-0391399-A1 | Electrophotographic photoreceptor | FUJI PHOTO FILM CO., LTD. (JP) | 1990-10-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090139134-A1 | BIOFUEL PRODUCTION | MGAM, DCXR, MANBA | CES1 73/4885CES2 60/4885FNTA 1376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.